Serum HER-2/neu decline predicts improved response to trastuzumab-based therapy in patients with normal and elevated baseline serum HER-2/neu levels Meeting Abstract

  


Authors: Ali, S. M.; Brault, D.; Brown-Shimer, S.; Carney, W.; Esteva, F. J.; Fornier, M.; Gligorov, J.; Hamer, P.; Harris, L.; Leitzel, K.; Kostler, W.; Lotz, J. P.; Luftner, D.; Pichon, M. F.; Thiel, R. P.; Tse, C.; Wheler, J.; Lipton, A.
Abstract Title: Serum HER-2/neu decline predicts improved response to trastuzumab-based therapy in patients with normal and elevated baseline serum HER-2/neu levels
Meeting Title: 29th Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Breast Cancer Research and Treatment
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2006 Dec 14-17
Meeting Location: San Antonio, TX
ISSN: 0167-6806
Publisher: Springer  
Date Published: 2006-12-01
Start Page: S90
Language: English
ACCESSION: WOS:000242047100260
PROVIDER: wos
PUBMED: 17187236
DOI: 10.1007/s10549-006-5678-0
Notes: --- - Meeting Abstract: 2030 - 29th Annual San Antonio Breast Cancer Symposium - DEC 14-17, 2006 - San Antonio, TX - "1" - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Jennifer Wheler
    11 Wheler
  2. Monica Nancy Fornier
    158 Fornier
Related MSK Work